/PRNewswire/ The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides,.
Beckman Coulter Diagnostics a clinical diagnostics leader and Fujirebio a leader in neurological markers and In Vitro Diagnostic IVD manufacturing today announced an expansion of their partnership focused on development manufacturing and clinical adoption of neurodegenerative disease assays.
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Danaher Corporation (NYSE:DHR) Q4 2023 Earnings Call Transcript January 30, 2024 Danaher Corporation beats earnings expectations. Reported EPS is $2.09, expectations were $1.9. Operator: Good morning. My name is Todd and I will be your conference facilitator this morning. At this time, I would like to welcome everyone to Danaher Corporation’s Fourth Quarter 2023 Earnings […]